These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 37990600)

  • 21. Evaluation of the effects of bitopertin (RG1678) on cardiac repolarization: a thorough corrected QT study in healthy male volunteers.
    Hofmann C; Banken L; Hahn M; Swearingen D; Nagel S; Martin-Facklam M
    Clin Ther; 2012 Oct; 34(10):2061-71. PubMed ID: 22980315
    [TBL] [Abstract][Full Text] [Related]  

  • 22. QT as a predictor of recurrence after atrial fibrillation ablation and the impact of amiodarone: results from the placebo-controlled AMIO-CAT trial.
    Diederichsen SZ; Darkner S; Chen X; Johannessen A; Pehrson S; Hansen J; Svendsen JH
    Europace; 2019 Jul; 21(7):1055-1062. PubMed ID: 30843038
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of intravenous ibutilide for rapid termination of atrial fibrillation and atrial flutter: a dose-response study.
    Ellenbogen KA; Stambler BS; Wood MA; Sager PT; Wesley RC; Meissner MC; Zoble RG; Wakefield LK; Perry KT; Vanderlugt JT
    J Am Coll Cardiol; 1996 Jul; 28(1):130-6. PubMed ID: 8752805
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Randomized, double-blind, crossover study to investigate the effect of rivaroxaban on QT-interval prolongation.
    Kubitza D; Mueck W; Becka M
    Drug Saf; 2008; 31(1):67-77. PubMed ID: 18095747
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thorough QT study of the effects of vildagliptin, a dipeptidyl peptidase IV inhibitor, on cardiac repolarization and conduction in healthy volunteers.
    He YL; Zhang Y; Serra D; Wang Y; Ligueros-Saylan M; Dole WP
    Curr Med Res Opin; 2011 Jul; 27(7):1453-63. PubMed ID: 21609207
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of a single oral dose of vanoxerine for the conversion of subjects with recent onset atrial fibrillation or flutter to normal sinus rhythm: RESTORE SR.
    Piccini JP; Pritchett EL; Davison BA; Cotter G; Wiener LE; Koch G; Feld G; Waldo A; van Gelder IC; Camm AJ; Kowey PR; Iwashita J; Dittrich HC
    Heart Rhythm; 2016 Sep; 13(9):1777-83. PubMed ID: 27108936
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of the Effect of Selumetinib on Cardiac Repolarization: A Randomized, Placebo- and Positive-controlled Crossover QT/QTc Study in Healthy Subjects.
    Zhou D; So K; Dymond AW; Vik T; Al-Huniti N; Mariani G; Zorenyi G; Huang Y; Holmes V; Severin P; Rasmussen S; Martin P
    Clin Ther; 2016 Dec; 38(12):2555-2566. PubMed ID: 27837934
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dasiglucagon Effects on QTc in Healthy Volunteers: A Randomized, Placebo-Controlled, Dose-Escalation, Double-Blind Study.
    Tehranchi R; Pettersson J; Melgaard AE; Seitz F; Valeur A; Maarbjerg SJ
    Curr Ther Res Clin Exp; 2022; 96():100668. PubMed ID: 35464292
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravenous Amisulpride Does Not Meaningfully Prolong the QTc Interval at Doses Effective for the Management of Postoperative Nausea and Vomiting.
    Fox GM; Albayaty M; Walker JL; Xue H; Darpo B
    Anesth Analg; 2021 Jan; 132(1):150-159. PubMed ID: 31913911
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Phase I, Randomized, Double-Blinded, Placebo- and Moxifloxacin-Controlled, Four-Period Crossover Study To Evaluate the Effect of Gepotidacin on Cardiac Conduction as Assessed by 12-Lead Electrocardiogram in Healthy Volunteers.
    Hossain M; Zhou M; Tiffany C; Dumont E; Darpo B
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28223381
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Droperidol and ondansetron-induced QT interval prolongation: a clinical drug interaction study.
    Charbit B; Alvarez JC; Dasque E; Abe E; Démolis JL; Funck-Brentano C
    Anesthesiology; 2008 Aug; 109(2):206-12. PubMed ID: 18648229
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized, placebo- and moxifloxacin-controlled thorough QT study of umeclidinium monotherapy and umeclidinium/vilanterol combination in healthy subjects.
    Kelleher D; Tombs L; Preece A; Brealey N; Mehta R
    Pulm Pharmacol Ther; 2014 Oct; 29(1):49-57. PubMed ID: 25020273
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The positive frequency-dependent electrophysiological effects of the IKur inhibitor XEN-D0103 are desirable for the treatment of atrial fibrillation.
    Ford J; Milnes J; El Haou S; Wettwer E; Loose S; Matschke K; Tyl B; Round P; Ravens U
    Heart Rhythm; 2016 Feb; 13(2):555-64. PubMed ID: 26455450
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Retrospective analysis of electrocardiographic changes after administration of oral or intravenous garenoxacin in five phase I, placebo-controlled studies in healthy volunteers.
    Wang Z; Grasela DM; Krishna G
    Clin Ther; 2007 Jun; 29(6):1098-106. PubMed ID: 17692724
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combination of olanzapine and samidorphan has no clinically relevant effects on ECG parameters, including the QTc interval: Results from a phase 1 QT/QTc study.
    Sun L; Yagoda S; Xue H; Brown R; Nangia N; McDonnell D; Rege B; von Moltke L; Darpo B
    Prog Neuropsychopharmacol Biol Psychiatry; 2020 Jun; 100():109881. PubMed ID: 32004636
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of Pradigastat, a Diacylglycerol Acyltransferase 1 Inhibitor, on the QTcF Interval in Humans.
    Meyers CD; Noe A; Salunke A; Movva A; Kulmatycki K; Neelakantham S; Crissey A; Majumdar T; Chen J
    Clin Pharmacol Drug Dev; 2016 Nov; 5(6):450-459. PubMed ID: 27274009
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conversion of atrial fibrillation to sinus rhythm and rate control by digoxin in comparison to placebo.
    Jordaens L; Trouerbach J; Calle P; Tavernier R; Derycke E; Vertongen P; Bergez B; Vandekerckhove Y
    Eur Heart J; 1997 Apr; 18(4):643-8. PubMed ID: 9129896
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of intravenous magnesium sulfate on the QT interval in patients receiving ibutilide.
    Caron MF; Kluger J; Tsikouris JP; Ritvo A; Kalus JS; White CM
    Pharmacotherapy; 2003 Mar; 23(3):296-300. PubMed ID: 12627926
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of the glucosylceramide synthase inhibitor lucerastat on cardiac repolarization: results from a thorough QT study in healthy subjects.
    Mueller MS; Sidharta PN; Voors-Pette C; Darpo B; Xue H; Dingemanse J
    Orphanet J Rare Dis; 2020 Oct; 15(1):303. PubMed ID: 33109218
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of nalmefene 20 and 80 mg on the corrected QT interval and T-wave morphology: a randomized, double-blind, parallel-group, placebo- and moxifloxacin-controlled, single-centre study.
    Matz J; Graff C; Vainio PJ; Kallio A; Højer AM; Struijk JJ; Kanters JK; Andersen MP; Toft E
    Clin Drug Investig; 2011 Nov; 31(11):799-811. PubMed ID: 21967071
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.